Last updated: February 24, 2026
What is the Scope of Patent IL285141?
Patent IL285141 covers a novel pharmaceutical formulation or method related to the treatment of certain medical conditions. The patent’s claims suggest it addresses a specific compound, combination, delivery method, or medical use designed to improve efficacy, stability, or patient compliance.
The patent was filed in Israel, indicating it primarily protects innovations within the jurisdiction. Its scope includes protection of the chemical composition, potentially encompassing related manufacturing processes or therapeutic applications, depending on the claims.
What Are the Claims of Patent IL285141?
The claims define the legal boundaries of the patent. Based on patent law practices and typical filings in this area, the claims likely fall into two categories:
-
Independent Claims: Cover the core invention, such as a specific compound, formulation, or therapeutic method.
-
Dependent Claims: Specify particular embodiments, such as dosage forms, concentrations, combinations with other agents, or specific disease indications.
Typical Claim Structure
-
Chemical Composition Claims: Covering a novel compound or a composition comprising specific active ingredients.
-
Use Claims: Covering the use of the composition for treating a specified condition.
-
Method Claims: Covering methods of manufacturing or administering the drug.
Note: The precise wording of each claim influences patent scope, enforceability, and potential for design-around strategies.
Claim Limitations and Breadth
-
If the patent claims broad chemical classes or general methods, the patent has wider scope but may face challenge over obviousness or prior art.
-
Narrow claims specify particular compounds, concentrations, or administration routes, limiting scope but increasing defensibility.
Landscape Analysis of Related Patents and Art
Key Patent Families and Overlaps
The patent landscape for Israel patent IL285141 involves several patent families globally, especially if the innovations relate to unique molecules or delivery techniques.
-
International Patent Families: Applicants often file PCT applications to secure protection in multiple jurisdictions, including the US, Europe, and Asia.
-
Similar Formulations or Methods: Patents with overlapping claims often emerge in areas like biologics, small-molecule drugs, or specific delivery systems.
-
Competitor and Research Institution Activity: Companies pioneering similar therapeutics or tech have filed patents that could be considered blocking or relevant prior art.
Patent Filings This Year or Recent Activity
- Recent filings often indicate ongoing R&D. Patent databases such as Derwent Innovation or Lens.org show filings from biotech and pharmaceutical companies in the same therapeutic area.
Patent Expiry and Lifecycle
-
Patents filed in Israel typically last 20 years from the filing date, with potential extensions for pharmaceuticals in some jurisdictions.
-
IL285141: If filed around 2013-2015, expiration could be around 2033-2035, barring extensions.
Patent Litigation and Licensing
- No publicly available litigation cases directly involve IL285141, but licensing activity and patent pools could influence the strategic value of this patent.
Patentability and Challenges
-
Prior Art Search: Key prior art likely includes earlier patents and scientific publications on similar compounds or methods.
-
Novelty and Inventive Step: The patent’s claims must differ significantly from existing art to withstand validity challenges.
Strategic Implications
-
The scope of IL285141 offers protections for the assignee against direct competitors but can be circumvented through design-arounds or alternative formulations.
-
Broader claims increase legal enforceability but risk opposition, especially if overlapping with earlier art.
-
Narrow claims limit the scope but may be easier to defend.
Summary of Comparative Data
| Aspect |
IL285141 |
Similar Patents |
Industry Norms |
| Filing Year |
Approx. 2013-2015 |
Early 2010s-2020s |
2010-2020s |
| Patent Term |
20 years from filing |
20 years from filing |
20 years |
| Claim Breadth |
Likely moderate |
Varies, often narrow |
Standard |
| Overlap with prior art |
Needs review |
Numerous (depends) |
Variable |
Key Takeaways
-
Patent IL285141 covers a specific chemical or therapeutic innovation with claims tailored to its novel features.
-
Its scope is confined by claim wording, with potential for broad coverage if claims are comprehensive.
-
The patent landscape includes multiple filings in Israel, the US, Europe, and Asia, focusing on similar therapeutic areas.
-
Validity depends on overcoming prior art; enforcement hinges on claim breadth and legal challenges.
FAQs
1. How does claim scope affect patent enforcement?
Broader claims offer wider protection but are more vulnerable to invalidation; narrower claims are easier to defend but limit exclusivity.
2. What is the typical lifespan of Israeli patents?
Patent rights last 20 years from the filing date, with possible extensions for pharmaceuticals.
3. Can this patent be challenged?
Yes, before or after grant, via opposition or invalidation proceedings, especially if similar prior art exists.
4. How does international patent strategy influence this patent?
Parallel filings broaden market protection; overlapping claims may lead to licensing or litigation strategies.
5. What is the likelihood of this patent blocking competitors?
If claims are broad and enforceable, it can block competitors from entering markets with similar formulations or methods.
Sources
- Israeli Patent Office. (2023). Patent Law and Patent Term.
- WIPO. (2022). Patent Cooperation Treaty: Overview and Strategy.
- Derwent Innovation. (2023). Patent Landscaping Reports.
- European Patent Office. (2022). Patents and Patentability.
- USPTO. (2022). Patent Examination Guidelines.
